| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Renfeng Guo | Chief Scientific Officer, Director | $1,638,793 | 18 Mar 2026 | ||
| Niels Riedemann | Chief Executive Officer, Director | $994,084 | 18 Mar 2026 | ||
| Mark Kubler | Director | $892,813 | 18 Mar 2026 | ||
| Nicolas Fulpius | Director | $455,748 | 18 Mar 2026 | ||
| Richard Brudnick | Director | $46,500 | 18 Mar 2026 | ||
| Anthony S. Gibney | Director | $9,300 | 18 Mar 2026 | ||
| Thomas Taapken | Chief Financial Officer | $3,255 | 18 Mar 2026 | ||
| Derval OCarroll | Officer | 18 Mar 2026 | |||
| Hege Hellstrom | Director | 18 Mar 2026 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Mark Kubler | IFRX | Ordinary Shares | 0 | 960,015 | 18 Mar 2026 | Direct | ||||
| Anthony S. Gibney | IFRX | Ordinary Shares | 0 | 10,000 | 18 Mar 2026 | Direct | ||||
| Richard Brudnick | IFRX | Ordinary Shares | 0 | 50,000 | 18 Mar 2026 | Direct | ||||
| Renfeng Guo | IFRX | Ordinary Shares | 0 | 1,762,144 | 18 Mar 2026 | Direct | ||||
| Nicolas Fulpius | IFRX | Ordinary Shares | 0 | 490,052 | 18 Mar 2026 | Direct | ||||
| Niels Riedemann | IFRX | Ordinary Shares | 0 | 1,068,908 | 18 Mar 2026 | Direct | ||||
| Thomas Taapken | IFRX | Ordinary Shares | 0 | 3,500 | 18 Mar 2026 | Direct |